by Ben | Jun 17, 2019 | Press Releases
CENTENNIAL, Colo., June 17, 2019 /PRNewswire/ — Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S. Food and Drug Administration’s (FDA) approval of the new Cochlear™ Nucleus®Profile™ Plus Series...